A broad spectrum of proteins has been detected within calcium stones. A newcomer to the field of urolithiasis is the blood protein inter-α-inhibitor. Inter-α-inhibitor comprises three protein chains linked by chondroitin sulphate : two heavy chains, H1 (65 kDa) and H2 (70 kDa) and a light chain (approx. 30 kDa) most commonly known as bikunin. The physiological function of the two heavy chains is unknown ; nor has their presence been reported in urine. However, bikunin has been implicated in various renal diseases, including urolithiasis.
INTRODUCTION
Inter-α-inhibitor (IαI) belongs to the Kunitz-type protein superfamily, a group of proteins possessing a common structural element (kunin) and the ability to inhibit serine proteases [1] . Protease inhibitors are widespread throughout the animal and plant kingdoms where they are responsible for limiting unwanted proteolysis [2] . However, despite the recognition of their gross function, specific details of their physiological roles have been identified only rarely. Although IαI is known to inhibit the action of trypsin, it accounts for less than 5 % of the anti-trypsin activity of serum [1] , and unequivocal evidence demonstrating that it significantly inhibits proteases in vivo has yet to be obtained.
IαI is a glycoprotein with a molecular mass of approximately 200 kDa circulating at a concentration of approximately 240 mg\l in mammalian plasma [3] . The intact protein has a complex structure which reflects its extraordinarily diverse genetic origins ( Figure 1 ). It Key words : bikunin, calcium stones, inter-α-inhibitor, kidney, urolithiasis.
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Correspondence : Professor R. L. Ryall. comprises two heavy chains, H1 and H2, linked covalently via a chondroitin sulphate moiety to a light chain previously referred to by a variety of names, including HI30, but now most commonly known as bikunin. Here we use the nomenclature proposed by Salier et al. [4] to describe IαI and related proteins. Bikunin circulates free in plasma and is excreted in urine where it degrades further to fragments HI14 and HI8 [5] . Two other variants have also been detected in blood : bikunin coupled with H2, which is now known as IαI H2,B (previously inter-α-like inhibitor), and bikunin linked to H1 (IαI H1,B) [6] . In primates, the picture is complicated further by the existence of a third heavy chain, H3, which, like H1, originates from p21.1-21.2 on chromosome 3 [1] , but is nonetheless the product of a separate gene ( Figure 1 ). Although not part of the IαI molecule, H3 can also link to bikunin to form the adduct IαI H3,B formerly known as pre-α-inhibitor, which is also found in plasma [1] .
A possible connection between IαI and stone disease
Figure 1 Schematic representation of IαI and its fragments
The multipolypeptide chains of the IαI family of molecules are encoded on several genes as well as the unrelated α1-microglobulin (α1m). Free bikunin, IαI, IαI H1,B, IαI H2,B (formerly known as inter-α-like inhibitor ; IαLI) and IαI H3,B (formerly known as pre-α-Inhibitor ; PαI) are some of the currently known derivatives of the IαI family detected in blood. Previously described by Salier [1] .
can be traced as far back as 1909, when Bauer and Reich demonstrated that the proteolytic activity of trypsin was inhibited by urine [7] , a property that has since been ascribed to what consequently became known as urinary trypsin inhibitor -an earlier name for IαI [8] . Since that study, other experimental evidence has raised the possibility that IαI may perform a regulatory function in stone pathogenesis. In 1990, Sørensen et al. [9] isolated a urinary protein which showed amino acid sequence identity to IαI. The fact that it inhibited calcium oxalate (CaOx) crystal growth in an inorganic crystallization system [9] led them to believe that the protein might play a role in CaOx stone formation. Subsequent investigations have reinforced this belief. A similar protein isolated from human urine, with a molecular mass of 35 kDa and containing 8.5 % carbohydrate, has also been reported to inhibit CaOx growth under similar conditions [10] . Because this protein was rich in uronic acid, a basic component of glycosaminoglycans, it was named uronicacid-rich protein (UAP). UAP from the urine of stone formers was reported to exhibit reduced inhibitory activity compared with that isolated from healthy subjects ; this was attributed to possible structural differences in the proteins from the two groups [11] . The protein has also been shown to share amino acid sequence identity with IαI [12] , an observation in keeping with other findings which demonstrated that two peptides with homology to bikunin inhibited the deposition of CaOx in inorganic milieux [13] . The electrophoretic and elution properties of one of these peptides, which had a molecular mass of 21 kDa, matched those of nephrocalcin [14] , a protein long associated with CaOx stone pathogenesis. Collectively these data suggested that what appeared to be distinct proteins were, in fact, either bikunin or one of its urinary fragments, and this has recently been confirmed [15] .
At the present time the putative relationship between IαI and stone formation is based almost entirely on the known presence of fragments of the protein in urine and the fact that they inhibit CaOx crystal growth in an inorganic reaction medium. Although bikunin is known to be present in CaOx crystals precipitated from normal human and rat urine [16] , to date, the H1 and H2 chains of IαI have not been reported to be present in urine, nor to participate in CaOx crystallization. No relationship between calcium stones and any part of the IαI molecule has been reported. Thus the aim of this study was to determine, using SDS\PAGE and Western blotting, whether IαI or any of its fragments are present in stones composed principally of calcium salts.
MATERIALS AND METHODS

Chemicals
All reagents used were of analytical grade and all solutions were prepared with high purity water (Permutit Australia, Brookvale, NSW, Australia 
Demineralization of stones
Renal stones composed principally of CaOx or calcium phosphate were obtained from patients attending Flinders Medical Centre (male\female l 3:1; age range 41-72 years). These corresponded to stones 1 to 10 used in a previous study [17] : full analytical data are provided in Table 1 of that paper. For this study, each stone was freshly ground to a fine powder using a mortar and pestle, and 100-mg samples were continually mixed for 48 h at 4 mC with 1.5 ml of 0.25 mol\l EDTA (pH 8.0) containing 0.02 % (w\v) sodium azide and 1 mmol\l benzamidine hydrochloride as described by Stapleton et al. [17] . The suspensions were centrifuged (Beckman GPR centrifuge) at 10 000 g for 5 min at 4 mC, the supernatant retained, and the pellets resuspended with 1.5 ml of EDTA and stirred for a further 48 h before recentrifugation. The supernatants resulting from each centrifugation step were pooled, filtered (0.2 µm Minisart2) and desalted by passage through a 1i26 cm Biogel P-6 DG column (Bio-Rad) using distilled water. The protein peak was collected, lyophilized and dissolved in 100 µl of SDS\PAGE reducing buffer (0.06 mol\l Tris pH 6.8, 10 % glycerol, 2 % SDS, 5 % β-mercaptoethanol, 0.01 % Bromophenol Blue), for analysis by SDS\PAGE.
SDS/PAGE
Samples were electrophoresed on 1-mm thick, 9-18 % gradient gels, using a Laemmli buffer system [18] with a Bio-Rad Mini-Protean II apparatus. A 15-well comb was inserted into a 6 % acrylamide stacking gel. The gels were stained with silver [19] and a duplicate of each was electrophoretically transferred for Western blotting as detailed below. Low-range molecular mass standard markers were obtained from Pharmacia (Uppsala, Sweden) for silver staining, and prestained markers (BioRad) were used for Western blotting.
Western blotting
Proteins were transferred from the gradient gels at 100 V for 1 h to Hybond-C extra nitrocellulose membranes (Amersham International, Bucks, U.K.) using the BioRad Mini-Protean II apparatus according to the method of Towbin et al. [20] . Immunochemical staining was performed at room temperature with shaking, and each incubation step lasted 1 h. The first incubation involved the blocking of non-specific binding sites on the nitrocellulose membranes with PBS (8 mmol\l K 
Purification and dissociation of standard IαI
In order to include a positive standard for Western blotting, IαI was purified from expired samples of Prothrombinex-HT, a concentrate of human blood coagulation factors manufactured from human plasma by CSL Bioplasma Ltd (Victoria, Australia). The intact IαI was purified by reconstituting the Prothrombinex-HT in pyrogen-free water and applying the sample to an HR 10\30 Sepharose 6 column (Pharmacia, Uppsala, Sweden). Chromatography was performed using citric acid\ phosphate buffer at pH 7.4 (0.2 mol\l NaH # PO % This was subsequently subjected to alkaline hydrolysis to obtain fragments of IαI (see below). Tryptic inhibitory activity was assayed by incubating the samples with trypsin (Type XIII : bovine) for 10 min at 37 mC in flat-bottomed microtitre plates (Titretek, Flow Laboratories, North Ryde, NSW, Australia), after the addition of the chromogenic trypsin substrate N-α-benzoyl-DL-arginine p-nitroanilide. Substrate (0.17 g) was dissolved in 10 ml of dimethyl sulphoxide and 10 ml of pyrogen-free water. The reaction was stopped by the addition of 1 mol\l citric acid monohydrate. The activity of the remaining trypsin was measured by recording the absorbance at 405 nm. The protein concentration of those samples with the highest total trypsin inhibitory units was measured by means of the Biuret reaction [21] .
Hydrolysis of IαI
Alkaline hydrolysis of intact IαI was based upon the methods of Malki et al. [22] and Michalski et al. [23] . Briefly, IαI (1.75 mg\ml) in a citric acid\phosphate buffer (see above) was adjusted to a pH of approximately 13.0 with NaOH and stirred for 10 min at room temperature. The reaction was stopped by neutralization with 2 mol\l HCl. The sample was then stored at k20 mC for later use.
RESULTS
Dissociation of IαI
Alkaline hydrolysis of IαI resulted in the formation of numerous fragments (shown in the far right hand lanes of the SDS\PAGE gel and Western blot in Figures 2 and 3 respectively). Most notable are the two H1 and H2 chains visible as discrete bands with molecular masses corresponding to 77 and 82 kDa respectively. Several protein bands are also present in the molecular mass range 20-40 kDa, some or all of which may correspond to the light chain bikunin or its fragments. With the rabbit antibikunin antibody, bands at 23.5 and 34.5 kDa were visible in the IαI hydrolysed standard (results not shown). Without amino-acid sequence analysis the positive identification of bikunin is impossible, as its molecular mass reportedly ranges from as low as 20 kDa [24] to as high as 70 kDa [25] and can also vary depending upon whether it is linked to the chondroitin sulphate moiety.
Several protein bands can also be seen in the range 10-20 kDa in the gel of hydrolysed IαI (Figure 2 ). These lower molecular mass fragments are not immunogenic with the rabbit anti-bikunin antibody but may be the HI14 and HI8 fragments of bikunin which have previously been found after degradation of IαI in vitro [5] . The rabbit anti-bikunin antibody may only recognize epitopes found in the intact bikunin molecule and hence further fragmentation may have prevented antibody binding.
Stone matrix extracts
Varying amounts of proteins are visible in the 10 stone matrix extracts (Figure 2 ), despite identical amounts of sample having been loaded on to the gels. The corresponding Western blot using the rabbit anti-human IαI antibody (Figure 3) shows the H1 and H2 chains of IαI in every stone extract except number 5 where no immunoreactivity was detected. The only other immunoreactivity with the rabbit anti-human IαI antibody was a smear of protein approximately 54-70 kDa in extract number 6.
Stone matrix extract number 6 was the only extract that displayed protein bands (approximately 34.5-41 kDa) indicative of reactivity to the rabbit anti-bikunin anti-body (results not shown). Bikunin therefore appears to be either a minor component in calcium stones or may be degraded some time after kidney stone formation.
DISCUSSION
Throughout nature, biomineralized tissues are closely associated with proteinaceous material which is often involved in the regulation of mineral deposition [26] . Human kidney stones can be considered as examples of pathological biomineralization, and, as occurs with their healthy counterparts, proteins and macromolecules are ubiquitously and invariably distributed throughout their structures [27] . Until relatively recently the identity of only a handful of individual proteins in matrix was known, largely because of methodological problems and the obstinate insolubility of stone matrix. However, advances in modern biotechnology have enabled the specific identification of an increasing number of stone proteins, and at least 19 individual proteins have now been shown to be present in stones. These include human serum albumin and α-and γ-globulins, Tamm-Horsfall glycoprotein, nephrocalcin, α1-microglobulin, haemoglobin and neutrophil elastase, osteopontin\uropontin, α1-antitrypsin, protectin, superoxide dismutase, β2-microglobulin, α1-acid glycoprotein, apolipoprotein A1, retinol-binding protein, and renal lithostathine and urinary prothrombin fragment 1 [28] . In this study we have shown that IαI can now be added to this ever-increasing list.
Both heavy chains of IαI were detected in all but one of the calculi examined (number 5). Their absence from stone 5 cannot be explained simply on the basis of the stone's mineral composition, which was remarkably similar to stone 2, and also to stones 6, 7 and 8, but instead may reflect a deficiency or complete lack of H1 and H2 in the urine of the individual in whom stone 5 was formed.
The possible origin of the two heavy chains of IαI in the stones is worthy of particular comment. With relative masses of around 77 and 82 kDa respectively, H1 and H2 are unlikely to be filtered directly from plasma, which contains high concentrations of IαI. They may, however, be secreted by the kidney, where immunoreactivity to IαI has been shown to be localized to the proximal convoluted tubules [29] , although it is not known if that reactivity is to the intact IαI molecule or to individual chains or fragments. The antibody used in that study was the same as that used in the present investigation, in which we detected cross-reactivity with the parent IαI molecule and a large number of its fragments, including bikunin, H1 and H2. However, as with all proteins detected in stones, the possibility must be entertained that the H1 and H2 chains may have originated directly from serum released by bleeding into the urinary tract.
The derivation of the organic content of stones from two possible sources has been a complicating factor in studies attempting to assess the role of matrix macromolecules in stone formation, since they can arise just as easily from the incorporation into CaOx crystals of components normally present in urine, as from constituents of plasma or structural material of cells released secondarily to tissue injury [30] . The simplest means of overcoming the inability to distinguish between the dual origin of matrix macromolecules is to study the organic components of CaOx crystals freshly precipitated from human urine, an approach that has facilitated the study of macromolecules which may regulate the crucial crystal formation phase of stone formation [30] . Although we cannot exclude completely the possibility that the H1 and H2 we observed in the stones may have been derived from haematuria, the likelihood is mitigated by the fact that they are also commonly present in healthy male and female urine free of blood and in CaOx crystals precipitated from them [31] .
The incorporation of H1 and H2 into crystals and, in consequence, in stones, almost certainly results from their irreversible binding to the CaOx crystal surface, which in turn may be related to the location of two γ-carboxyglutamic acid residues within the heavy chain region of IαI [32] , and which are renowned for their extraordinary ability to bind calcium ions. It is noteworthy that calcium stones also contain two other urinary γ-carboxyglutamic acid proteins [28] , namely urinary prothrombin fragment 1, which is the predominant protein in CaOx urinary crystals, and nephrocalcin, which recent work has suggested may be related to IαI [13] . The heavy chains of IαI are also known to contain amino acid sequences (aspartic acid-asparagine-asparagine-aspartic acid) which are known to bind calcium avidly [33] . The presence of both heavy chains of IαI in stones is therefore perfectly consistent with their presence in both urine and CaOx crystals. However, the same cannot be said for the light chain of IαI.
Bikunin, with which the anti-tryptic activity of IαI is associated [34] , is well known to be present in urine [8] , as are its fragments HI14 and HI8 [5] . Using an antibody which specifically reacts with bikunin, a 35-kDa form of the peptide has been shown to be present in trace amounts in CaOx crystals precipitated from human and rat urine [16] ; a form with a molecular mass of approx. 45 kDa was also infrequently seen. We have also shown [31] that normal male and female human urine, as well as CaOx crystals deposited from it, contains protein bands with similar molecular masses. The presence of bikunin, detected by the rabbit anti-bikunin antibody, in only one CaOx stone may seem puzzling, because if bikunin were important in stone formation one would expect it to be present in all the stone matrix extracts. However, the absence of bikunin-like peptides does not necessarily mean that they were not originally present in the stones.
Degradation of matrix macromolecules as a result of ageing during long-term storage is well recognized [35] , and the stones used here had been collected from patients at least 5 years previously. Fragmentation could also have been caused by urinary proteases or bacteria while the stones were still in the urinary tract. We cannot exclude the possibility that the bikunin-like peptides observed in CaOx crystals by Atmani et al. [16] and ourselves may be breakdown products of one of the numerous combinations of the various chains of IαI, caused by the crystallization process itself, which unlike crystal formation in vivo was induced by extremely high concentrations of oxalate. These peptides were obvious in the gels and blots of the hydrolysed IαI used as a standard, which confirms previous reports that alkaline hydrolysis causes significant fragmentation of the IαI molecule [22, 23] . A large and confusing array of protein bands, all of which reacted with the IαI antibody, were seen after alkaline treatment of intact IαI. These most probably represent various combinations of the component peptide chains of IαI, both with and without the chondroitin sulphate chain. The picture becomes even more confused in the light of evidence that plasma contains an additional heavy chain (H3), which can also associate with bikunin to form IαI H3,B, another protein member of the IαI family with a molecular mass of 125 kDa.
It is becoming increasingly obvious that the IαI family is highly complex, comprising molecules involving all three heavy chains and bikunin in a wide range of combinations, and possibly also associated with other unrelated proteins [1] . Although it is unlikely that the H1, H2 and H3 chains all combine with bikunin in a single IαI molecule [1] , in the present study the Western blots of the hydrolysed IαI, which was derived from human blood, showed the presence of bands in the region of H3, which has a molecular mass of 90 kDa [36] . Immunoreactivity of H3 would be expected with the antibody used here, because there is marked similarity between H1 and H3 amino acid and nucleotide sequences [37] . Reaction would also be expected with intact IαI H3,B, which contains the HI30 chain. However, although higher molecular mass bands were seen in the hydrolysed IαI standard, they were not consistently observed in the extracts of the stones.
The results of this study have clearly demonstrated that the role of IαI and its derivatives in urolithiasis is far more complicated than has been suggested by previous work in which only the bikunin portion of the molecule was examined. In fact, it would appear that the involvement of bikunin in CaOx crystallization in urine is minor [16, 31] in comparison with the two heavy chains of IαI, both of which, unlike bikunin, are consistently present in urine and CaOx crystals [31] , and in stones. However, although the very presence of H1 and H2, or indeed any protein, in stones suggests that they may influence the course of mineral deposition, it cannot be assumed that they unambiguously fulfil a specific regulatory function in stone formation.
The paradoxical presence in stones of molecules known to inhibit CaOx crystallization has long been a conundrum. The phenomenon results from the fact that inhibitors retard crystallization processes ; they do not necessarily completely prevent them, especially in the face of very high levels of supersaturation. Under these circumstances even the most potent inhibitor would be overwhelmed and would become embedded within the architecture of the stone as the growth front passes over it. Previous work has certainly shown that bikunin inhibits CaOx crystal growth [9, 10, 12, 13] , but those studies were conducted using inorganic solutions, and it is possible that bikunin has little, if any, inhibitory activity in urine. Nonetheless, it is now clear that significant cleavage of IαI occurs in urine, and that several fragments of the molecule can participate in CaOx crystal formation in urine : these may, consequently, play some regulatory role in calcium stone formation. Elucidation of the role of IαI and its derivatives in calcium urolithiasis requires further studies which should, at least in the first instance, include the assessment of the relative inhibitory effects of bikunin, H1 and H2 on CaOx crystallization in urine.
